Araştırma Makalesi

Cognitive Insight and Self-Efficacy in Patients with Schizophrenia

Cilt: 11 Sayı: 2 21 Haziran 2026
PDF İndir
EN TR

Cognitive Insight and Self-Efficacy in Patients with Schizophrenia

Öz

Objective: This study aimed to determine cognitive insight and self-efficacy levels in individuals with schizophrenia. Materials and Methods: This descriptive, correlational, cross-sectional study was conducted between July 1 and October 1, 2025. A total of 103 patients diagnosed with schizophrenia according to the DSM-5 diagnostic criteria were included. Data were collected using a Personal Information Form, the Beck Cognitive Insight Scale (BCIS), and the Self-Efficacy–Competence Level Scale (SECLS). Statistical analyses were performed using IBM SPSS for Windows (SPSS Statistics Base v23, IBM). A p-value of <0.05 was considered statistically significant. Results: The mean total BCIS score was 2.63±4.35, and the mean total SECLS score was 71.50±11.86. A statistically significant, negative, and moderate correlation was found between the Beck Cognitive Insight Scale and the Self-Efficacy–Competence Level Scale (r=−0.443, p<0.001). Conclusion: A negative relationship was found between cognitive insight and self-efficacy in individuals with schizophrenia. This finding indicates that the development of insight should be addressed together with emotional adaptation, self-perception, and the recovery process. In this context, psychiatric nursing interventions should support cognitive insight while simultaneously strengthening patients’ perceived self-efficacy, hope, coping skills, stigma resistance, and recovery-oriented functioning. Psychoeducational and anti-stigma interventions may help patients integrate illness awareness without weakening their perceived competence.

Anahtar Kelimeler

Destekleyen Kurum

None

Etik Beyan

Before the study commenced, ethical approval was obtained from the Non-Interventional Clinical Research Ethics Committee of the Faculty of Health Sciences at Yalova University (Date: 23.05.2025, Decision no: 2025/203). In addition, institutional permission was obtained from the Provincial Directorate of Health to which the relevant training and research hospital, where the study was conducted, is affiliated (Date: 27.06.2025, Decision no: E-51301208-605-280215212). The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants in the study.

Teşekkür

None

Kaynakça

  1. 1- Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211-224. doi:10.1016/S2215-0366(18)30511-X
  2. 2- Andreasen NC. Schizophrenia: positive and negative symptoms and syndromes. Int Clin Psychopharmacol. 1990;5(Suppl 1):234.
  3. 3- Xu L, Xu T, Tan W, et al. Household economic burden and outcomes of patients with schizophrenia after being unlocked and treated in rural China. Epidemiol Psychiatr Sci. 2019;29:e81. doi:10.1017/S2045796019000775
  4. 4- Lysaker P, Pattison M, Leonhardt B, Phelps S, Vohs J. Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatry. 2018;17(1):12-23. doi:10.1002/wps.20508
  5. 5- Kim J, Ozzoude M, Nakajima S, et al. Insight and medication adherence in schizophrenia: an analysis of the CATIE trial. Neuropharmacology. 2020;168:107634. doi:10.1016/j.neuropharm.2019.05.011
  6. 6- Van Camp LSC, Sabbe BGC, Oldenburg JFE. Cognitive insight: a systematic review. Clin Psychol Rev. 2017;55:12-24. doi:10.1016/j.cpr.2017.04.011
  7. 7- Beck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr Res. 2004;68(2-3):319-329. doi:10.1016/S0920-9964(03)00189-0
  8. 8- Orfei MD, Porcari DE, Spalletta G, et al. The Italian validation of the Beck Cognitive Insight Scale: underlying factor structure in psychotic patients and the general population. Int J Environ Res Public Health. 2023;20(17):6634. doi:10.3390/ijerph20176634

Ayrıntılar

Birincil Dil

İngilizce

Konular

Ruh Sağlığı Hemşireliği

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

21 Haziran 2026

Gönderilme Tarihi

5 Ocak 2026

Kabul Tarihi

14 Haziran 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 11 Sayı: 2

Kaynak Göster

APA
Adıgüzel, V., & Şahpolat, M. (2026). Cognitive Insight and Self-Efficacy in Patients with Schizophrenia. Online Turkish Journal of Health Sciences, 11(2), 174-181. https://doi.org/10.26453/otjhs.1857106
AMA
1.Adıgüzel V, Şahpolat M. Cognitive Insight and Self-Efficacy in Patients with Schizophrenia. OTSBD. 2026;11(2):174-181. doi:10.26453/otjhs.1857106
Chicago
Adıgüzel, Vesile, ve Musa Şahpolat. 2026. “Cognitive Insight and Self-Efficacy in Patients with Schizophrenia”. Online Turkish Journal of Health Sciences 11 (2): 174-81. https://doi.org/10.26453/otjhs.1857106.
EndNote
Adıgüzel V, Şahpolat M (01 Haziran 2026) Cognitive Insight and Self-Efficacy in Patients with Schizophrenia. Online Turkish Journal of Health Sciences 11 2 174–181.
IEEE
[1]V. Adıgüzel ve M. Şahpolat, “Cognitive Insight and Self-Efficacy in Patients with Schizophrenia”, OTSBD, c. 11, sy 2, ss. 174–181, Haz. 2026, doi: 10.26453/otjhs.1857106.
ISNAD
Adıgüzel, Vesile - Şahpolat, Musa. “Cognitive Insight and Self-Efficacy in Patients with Schizophrenia”. Online Turkish Journal of Health Sciences 11/2 (01 Haziran 2026): 174-181. https://doi.org/10.26453/otjhs.1857106.
JAMA
1.Adıgüzel V, Şahpolat M. Cognitive Insight and Self-Efficacy in Patients with Schizophrenia. OTSBD. 2026;11:174–181.
MLA
Adıgüzel, Vesile, ve Musa Şahpolat. “Cognitive Insight and Self-Efficacy in Patients with Schizophrenia”. Online Turkish Journal of Health Sciences, c. 11, sy 2, Haziran 2026, ss. 174-81, doi:10.26453/otjhs.1857106.
Vancouver
1.Vesile Adıgüzel, Musa Şahpolat. Cognitive Insight and Self-Efficacy in Patients with Schizophrenia. OTSBD. 01 Haziran 2026;11(2):174-81. doi:10.26453/otjhs.1857106

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya derginin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.